Related Experiment Video
Updated: Jul 7, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002
A D Cunningham1, C J Plummer, J M McComb
1National Pacemaker and ICD Database, UK. david@ccad.nildram.co.uk
Implantable cardioverter-defibrillator (ICD) use in the UK rose from 1998-2002 but remained below European averages and targets, with significant regional variations. Further research is needed to understand these disparities in evidence-based treatment delivery.
Area of Science:
- Cardiology
- Public Health
- Medical Device Technology
Background:
- Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden cardiac death.
- European and national guidelines recommend ICDs for specific patient groups.
- Understanding implantation trends is vital for assessing healthcare access and effectiveness.
Purpose of the Study:
- To quantify the rate of ICD implantation in the United Kingdom between 1998 and 2002.
- To compare UK ICD implantation rates with European averages and national objectives.
- To identify geographical variations in ICD uptake across the UK.
Main Methods:
- An observational study design was employed, utilizing self-reported data with cross-checking for accuracy.
- Data collection was coordinated by the National Pacemaker and ICD Database, encompassing all UK ICD implanting centers.
- The study included all patients who received an ICD in the UK from 1998 to 2002, recording implantation dates and patient postcodes.
Main Results:
- ICD implantation rates in the UK demonstrated an increase over the five-year study period.
- Despite the increase, UK implantation rates significantly lagged behind the European average and established national targets.
- Substantial regional disparities in ICD implantation rates were observed across the United Kingdom.
Conclusions:
- The study highlights a concerningly low rate of ICD implantation in the UK.
- Significant regional variations in access to this evidence-based therapy were identified.
- Further investigation is warranted to elucidate the barriers hindering wider adoption of ICDs in the UK.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

